RxDoctor Payments Data

Michelle Worthen, APRN

Family · Tallahassee, FLNPI 1972177996

Payments from drug & device makers

$596in general payments, 2019–2025

Across 25 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exelixis Inc.$80
  • E.r. Squibb & Sons, L.L.C.$56
  • Stemline Therapeutics Inc.$53
  • Novartis$50
  • Eisai Inc.$45
  • Johnson & Johnson$41
  • plus $271 from 12 others

What the payments were for

  • Food & beverage$51687%
  • Education$8013%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$596 in reported general payments places this provider in the 60th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$11,139
Medicare patients
88
Services billed
125

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept40$278,843
Humira(Cf) PenAdalimumab16$109,348
SimponiGolimumab11$65,454
KevzaraSarilumab11$43,595
Actemra ActpenTocilizumab12$43,033
Hydroxychloroquine Sulfate122$4,923
MethotrexateMethotrexate Sodium106$2,601
Colchicine22$1,570
Celecoxib17$1,372
Prednisone125$889
Leflunomide11$688
Sulfasalazine26$392
Allopurinol41$337
Methylprednisolone12$133
Folic Acid13$119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSimponi$41$65,45411 claims
SanofiKevzara$31$43,59511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 14,618 family providers in Florida.

Other family in Tallahassee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →